Drug Discovery Market Research Reports & Industry Analysis

Drug discovery is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will actually yield products that achieve regulatory approval by the Food & Drug Administration (FDA). The average drug can take 10+ years to progress from the discovery phase to the clinic, with only one compound out of 10,000 evolving into a viable product. Need for discovery is driven by the need for new products to market and sell. 

Sort by

United States Alzheimer’s Disease Drug Market by Manufacturers, States, Type and Application, Forecast to 2022

14 Jun 2017  |  Published by:  Global Info Research
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.Scope of the Report:This report focuses on the Alzheimer’s Disease Drug in United States marke...
$ 4,480.00 Read More

United States Bacterial Vaginosis Drug Market by Manufacturers, States, Type and Application, Forecast to 2022

14 Jun 2017  |  Published by:  Global Info Research
This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria.Scope of the Report:This report focuses on t...
$ 4,480.00 Read More

United States Drugs for Malaria Market by Manufacturers, States, Type and Application, Forecast to 2022

14 Jun 2017  |  Published by:  Global Info Research
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of ...
$ 4,480.00 Read More

United States Onychomycosis (Tinea Unguium) Drug Market by Manufacturers, States, Type and Application, Forecast to 2022

14 Jun 2017  |  Published by:  Global Info Research
Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.Scope of the Report:This report focuses on the Onychomycosis (Tinea ...
$ 4,480.00 Read More

2017 Top 5 Fosfomycin Trometamol Manufacturers in North America, Europe, Asia-Pacific, South America, Middle East and Africa

13 Jun 2017  |  Published by:  LP INFORMATION
The Global Fosfomycin Trometamol market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.This report studies Fosfomycin Trometamol in Global market, especially in North America, Europe, Asia-Pacific, South Ameri...
$ 4,960.00 Read More

2017-2022 Global Top Countries Fosfomycin Trometamol Market Report

13 Jun 2017  |  Published by:  LP INFORMATION
The Global Fosfomycin Trometamol market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.This report studies Fosfomycin Trometamol in Global market, especially in United States, Canada, Mexico, Germany, France, ...
$ 4,960.00 Read More

2017-2022 China Fosfomycin Trometamol Market Report (Status and Outlook)

13 Jun 2017  |  Published by:  LP INFORMATION
The Fosfomycin Trometamol market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In China market, the top players includeZambonNorthesat PharmHunan Huana PharmaceuticalsXunda PharmaFarmaSino Pharmaceut...
$ 3,360.00 Read More

2017-2022 India Fosfomycin Trometamol Market Report (Status and Outlook)

13 Jun 2017  |  Published by:  LP INFORMATION
The Fosfomycin Trometamol market size will be XX million (USD) in 2022 in India, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In India market, the top players includeZambonNorthesat PharmHunan Huana PharmaceuticalsXunda PharmaFarmaSino Pharmaceut...
$ 3,360.00 Read More

2017-2022 Japan Fosfomycin Trometamol Market Report (Status and Outlook)

13 Jun 2017  |  Published by:  LP INFORMATION
The Fosfomycin Trometamol market size will be XX million (USD) in 2022 in Japan, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In Japan market, the top players includeZambonNorthesat PharmHunan Huana PharmaceuticalsXunda PharmaFarmaSino Pharmaceut...
$ 3,360.00 Read More

2017-2022 Malaysia Fosfomycin Trometamol Market Report (Status and Outlook)

13 Jun 2017  |  Published by:  LP INFORMATION
The Fosfomycin Trometamol market size will be XX million (USD) in 2022 in Malaysia, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In Malaysia market, the top players includeZambonNorthesat PharmHunan Huana PharmaceuticalsXunda PharmaFarmaSino Phar...
$ 3,360.00 Read More

2017-2022 Philippines Fosfomycin Trometamol Market Report (Status and Outlook)

13 Jun 2017  |  Published by:  LP INFORMATION
The Fosfomycin Trometamol market size will be XX million (USD) in 2022 in Philippines, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In Philippines market, the top players includeZambonNorthesat PharmHunan Huana PharmaceuticalsXunda PharmaFarmaSin...
$ 3,360.00 Read More

2017-2022 United States Fosfomycin Trometamol Market Report (Status and Outlook)

13 Jun 2017  |  Published by:  LP INFORMATION
The Fosfomycin Trometamol market size will be XX million (USD) in 2022 in United States, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In United States market, the top players includeZambonNorthesat PharmHunan Huana PharmaceuticalsXunda PharmaFarm...
$ 3,360.00 Read More

2017 Top 5 Softgel Capsules Manufacturers in North America, Europe, Asia-Pacific, South America, Middle East and Africa

12 Jun 2017  |  Published by:  LP INFORMATION
The Global Softgel Capsules market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.This report studies Softgel Capsules in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle...
$ 4,960.00 Read More

2017-2022 Global Top Countries Osteoporosis Drugs Market Report

12 Jun 2017  |  Published by:  LP INFORMATION
The Global Osteoporosis Drugs market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.This report studies Osteoporosis Drugs in Global market, especially in United States, Canada, Mexico, Germany, France, UK, It...
$ 4,960.00 Read More

2017-2022 China Softgel Capsules Market Report (Status and Outlook)

12 Jun 2017  |  Published by:  LP INFORMATION
The Softgel Capsules market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In China market, the top players includeAenovaCatalentCapsugelEuroCapsPatheonNBTYGAPNutrition GroupBee HealthThis report with...
$ 3,360.00 Read More
  • 1662 Results